1The impact of hypoxic-ischemic brain injury on stem cell mobilization, migration, adhesion, and proliferationStephanie M.Parry, Eric S.Peeples1125-11352Subcellular localization of alpha-synuclein aggregates and their interaction with membranesFabiana Miraglia, Alessio Ricci, Lucia Rota, Emanuela Colla1136-11443Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve visionNajam A.Sharif1145-11504Factors that modulate olfactory dysfunctionKate Beecher, James A.St John, Fatemeh Chehrehasa1151-11555What can computational modeling offer for studying the Ca2+ dysregulation in Alzheimer's disease: current research and future directionsJingyi Liang, Don Kulasiri1156-11586Molecular mechanism of noradrenaline during the stress-induced major depressive disorderKenjiro Seki, Satomi Yoshida, Manoj Kumar Jaiswal1159-11697Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer's diseaseJ(o)rg Flemmig, Marcel Zámock(y), A Alia1170-11748Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhageHidenori Suzuki, Hirofumi Nishikawa, Fumihiro Kawakita1175-11789Optimization of nanofiber scaffold properties towards nerve guidance channel designGraham Ka-Hon Shea, Francis Mok1179-118010Vascular endothelial growth factor: an essential neurotrophic factor for motoneurons?Paula M.Calvo, Angel M.Pastor, Rosa R.de la Cruz1181-118211Bone morphogenetic protein signaling: a promising target for white matter protection in perinatal brain injuryJill Chang, Robert W.Dettman, Maria L.V.Dizon1183-118412Neurodegenerative diseases are a function of matrix breakdown: how to rebuild extracellular matrix and intracellular matrixGreg Maguire1185-118613Brain repair for Parkinson's disease: is the answer in the matrix?Niamh Moriarty, Eilís Dowd1187-118814Developing biomarkers for neurodegenerative diseases using genetically-modified common marmoset modelsIkuo Tomioka, Yoshitaka Nagai, Kazuhiko Seki1189-119015Histone methylation in Huntington's disease: are bivalent promoters the critical targets?Nóra Zsindely, László Bodai1191-119216Lateral olfactory tract usher substance (LOTUS) protein, an endogenous Nogo receptor antagonist, converts a non-permissive to permissive brain environment for axonal regrowthTomoko Hirokawa, Kohtaro Takei1193-119417Houshiheisan and its components promote axon regeneration after ischemic brain injuryYue Lu, Flora Hsiang, Jia-Hui Chang, Xiao-Quan Yao, Hui Zhao, Hai-Yan Zou, Lei Wang, Qiu-Xia Zhang1195-120318Ginkgolide B promotes the proliferation and differentiation of neural stem cells following cerebral ischemia/reperfusion injury, both in vivo and in vitroPei-Dong Zheng, Rajneesh Mungur, Heng-Jun Zhou, Muhammad Hassan, Sheng-Nan Jiang, Jie-Sheng Zheng1204-121119Is transesophageal echocardiography needed for evaluating tissue-based transient ischemic attack?Mohamed Al-Khaled, Bj(o)rn Scheef, Toralf Brüning1212-121520MicroRNA-219 alleviates glutamate-induced neurotoxicity in cultured hippocampal neurons by targeting calmodulin-dependent protein kinase Ⅱ gammaTing Wang, Qun Cai, Wen-Jie Yang, Hai-Hua Fan, Jian-Feng Yi, Feng Xu1216-1224 